{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:58:23Z","timestamp":1781668703585,"version":"3.54.5"},"reference-count":72,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["chemistry-europe.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["ChemPhysChem"],"published-print":{"date-parts":[[2026,6,15]]},"abstract":"<jats:p>Poly(ADP\u2010ribose) polymerases (PARPs) have emerged as pivotal therapeutic targets due to their essential function in DNA single\u2010strand break repair, particularly in cancers with BRCA1\/2 mutations. Although PARP inhibitors show promising clinical responses, their long\u2010term efficacy is often compromised by the development of drug resistance, which limits sustained therapeutic success. To address this, identifying molecules capable of modulating additional cancer\u2010relevant pathways has become an emerging strategy. G\u2010quadruplexes (G4s), enriched in oncogenic promoter regions, have gained considerable attention as therapeutic targets. In this study, we investigated the ability of two PARP inhibitors, PARP inhibitor VIII (PI VIII) and PARP inhibitor XI (PI XI), to bind and stabilize G4 structures using biophysical assays and molecular docking. Our results reveal that PI VIII exhibits a markedly stronger affinity for G4 structures compared to PI XI, with a preference for the G4 motif present in the c\u2010myc oncogene, which is frequently overexpressed in cancer cells. Moreover, PI VIII demonstrates enhanced binding and stabilization of the c\u2010myc G4 relative to duplex DNA. The observed stabilizing effect involves electrostatic interactions, hydrogen bonding, and \u03c0\u2013\u03c0 stacking. These findings identify PI VIII as a promising dual\u2010mode anticancer candidate capable of simultaneously inhibiting PARP activity and stabilizing oncogenic G\u2010quadruplexes.<\/jats:p>","DOI":"10.1002\/cphc.70443","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:30:07Z","timestamp":1781245807000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual Functional Potential of Poly(ADP\u2010Ribose) Polymerase Inhibitor VIII: A Promising G\u2010Quadruplex Stabilizer Targeting the Promoter of Oncogenes"],"prefix":"10.1002","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6963-4325","authenticated-orcid":false,"given":"Asim","family":"Bisoi","sequence":"first","affiliation":[{"name":"School of Chemical Science Indian Association for the Cultivation of Science  Jadavpur India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9357-9039","authenticated-orcid":false,"given":"Prashant Chandra","family":"Singh","sequence":"additional","affiliation":[{"name":"School of Chemical Science Indian Association for the Cultivation of Science  Jadavpur India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms141021087"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2022.10.006"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116535"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2019.1654458"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16101320"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-010-0490-8"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/pcmedi\/pbaa030"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33918"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevEukaryotGeneExpr.2013006875"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.382"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0027-5107(01)00111-7"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2025.103873"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.5732\/cjc.011.10111"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1133472"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15082357"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2016.311"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2013.01.006"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom14101269"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20095"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2010.103"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0425-1"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2025.103000"},{"key":"e_1_2_8_24_1","first-page":"402","article-title":"Rucaparib and Niraparib in Advanced Ovarian Cancer","volume":"10","author":"Redelico T.","year":"2019","journal-title":"Journal of the Advanced Practitioner in Oncology"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1718"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm5018237"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz192"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-12-0950"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016600"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2010.01840.x"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.290957.116"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v12.i7.544"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15143642"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1414112"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1354427"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102410"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1177\/10732748241298329"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-03227-6"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkl655"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-9666-7_1"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv862"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2022.01.197"},{"key":"e_1_2_8_43_1","first-page":"13","article-title":"Quadruplexes in Tumor Immune Regulation: Molecular Mechanisms and Therapeutic Prospects in Gastrointestinal Cancers","author":"Zhou Y.","year":"2025","journal-title":"Biomedicines"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01328-4"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.2c00337"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2013.833187"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122481"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2009.04.637"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-015-0217-2"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.00538"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41540-024-00453-2"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2012.08.019"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja511680u"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.3c00585"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi048242p"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1039\/C7MD00094D"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2013.08.009"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2018.07.092"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jpcb.2c08265"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jpcb.3c03042"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2025.143531"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/cptc.202400241"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.334516.119"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03445"},{"key":"e_1_2_8_65_1","first-page":"608","article-title":"echanisms of Resistance to PARP Inhibitors \u2010 An Evolving Challenge in Oncology","volume":"2","author":"Mweempwa A.","year":"2019","journal-title":"Cancer Drug Resistance"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01227-0"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5c01058"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.344"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1179"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpc.2024.107330"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa1172"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b01563"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-83474-9"}],"container-title":["ChemPhysChem"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/chemistry-europe.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cphc.70443","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/chemistry-europe.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cphc.70443","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/chemistry-europe.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cphc.70443","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:32:52Z","timestamp":1781667172000},"score":1,"resource":{"primary":{"URL":"https:\/\/chemistry-europe.onlinelibrary.wiley.com\/doi\/10.1002\/cphc.70443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":72,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,6,15]]}},"alternative-id":["10.1002\/cphc.70443"],"URL":"https:\/\/doi.org\/10.1002\/cphc.70443","archive":["Portico"],"relation":{},"ISSN":["1439-4235","1439-7641"],"issn-type":[{"value":"1439-4235","type":"print"},{"value":"1439-7641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"2025-12-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70443"}}